Phosphagenics to Exhibit at Jefferies Healthcare Conference

Jun 19, 2007, 01:00 ET from Phosphagenics Limited

    MELBOURNE, Australia, June 19 /PRNewswire-FirstCall/ -- Phosphagenics
 Limited (ASX: POH) (AIM: PSG) (ADR/OTC: PPGNY) announced today that Harry
 Rosen, Chief Executive Officer, and Dr. Esra Ogru, Executive Vice
 President, will host a table-top presentation around the Jefferies
 Healthcare Conference at the conference reception being held at Per Se in
 the Time Warner Center in New York on Wednesday, June 27th, 2007 from 5:00
 PM to 8:00 PM ET.
     In addition, the Company will be available for one-on-one meetings
 during the week of the conference.
     About Phosphagenics Limited
     Phosphagenics is a Melbourne-based, globally driven biotechnology
 company focused on the discovery of new and cost effective ways to enhance
 the bioavailability, activity, safety and delivery of proven pharmaceutical
 and nutraceutical products. The Company's core technology is built around
 the science and application of phosphorylation, a process where the
 addition of a phosphate group has been found to enhance the
 bioavailability, activity and safety of existing pharmaceuticals and
 nutraceuticals, as well as to assist in the production of drug delivery
 platforms. Phosphagenics' shares are listed on the Australian Stock
 Exchange (POH) and the London Stock Exchange's Alternative Investment
 Market (PSG). An ADR - Level 1 program has been established in the US with
 the Bank of New York (PPGNY) for US investors to trade in Phosphagenics'
 stock on the 'over-the-counter' market.
     For more information, please visit Phosphagenics' web site at

SOURCE Phosphagenics Limited